Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial
World Journal of Urology · 21.02.2024 · 42 (1)
DOI: 10.1007/s00345-024-04819-3 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift World Journal of Urology, online erschienen am 21.02.2024. Verfasst von Mengchao Wei und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng, Beijin…. Hauptthemen laut MEDLINE: Robotic Surgical Procedures, Robotics, Insufflation, Laparoscopy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National High Level Hospital Clinical Research Funding.
Abstract (Originalsprache)
Purpose
AirSeal is a valve-less trocar insufflation system which is widely used in robotic urologic surgeries. More evidence is needed concerning the application and cost of AirSeal in retroperitoneal robot-assisted laparoscopic partial nephrectomy.
Methods
We conducted a randomized controlled trial enrolling 62 patients who underwent retroperitoneal robot-assisted laparoscopic partial nephrectomy from February 2022 to February 2023 in the Peking Union Medical College Hospital. Patients were randomly assigned into AirSeal insufflation (AIS) group and conventional insufflation (CIS) group. The primary outcome was the rate of subcutaneous emphysema (SCE).
Results
The SCE rate in the AIS group (12.9%) was significantly lower than that in the CIS group (35.5%) ( P = 0.038). Lower maximum end-tidal carbon dioxide (CO 2 ) (41 vs 45 mmHg, P = 0.011), PaCO 2 at the end of the operation (40 vs 45 mmHg, P < 0.001), maximum tidal volume (512 vs 570 ml, P = 0.003), frequency of lens cleaning (3 vs 5, P < 0.001), pain score at 8 h (3 vs 4, P = 0.025), 12 h (2 vs 3, P = 0.029) postoperatively and at time of discharge (1 vs 2, P = 0.002) were observed in the AIS group, despite a higher hospitalization cost (68,197 vs 64658RMB, P < 0.001). Logistic regression analysis identified insufflation approach was the only influencing factor for the occurrence of SCE events.
Conclusion
AirSeal insufflation system exhibited similar efficacy and improved safety for retroperitoneal robot-assisted laparoscopic partial nephrectomy than conventional insufflation system, despite an affordable increase of hospitalization costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng, Beijing, 100000, China.
- Department of Urology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Dongcheng, Beijing, 100000, China. pumchdongjie@163.com.
Förderung
- the National High Level Hospital Clinical Research Funding
Zitieren
APA
Wei, M., Yang, W., Zhou, J., Ye, Z., Ji, Z., Dong, J., & Xu, W. (2024). Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial. World Journal of Urology, 42(1). https://doi.org/10.1007/s00345-024-04819-3
Vancouver
Wei M, Yang W, Zhou J, Ye Z, Ji Z, Dong J, et al. Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial. World Journal of Urology. 2024;42(1). doi:10.1007/s00345-024-04819-3
BibTeX
@article{Wei2024,
author = {Wei, Mengchao and Yang, Wenjie and Zhou, Jingmin and Ye, Zixing and Ji, Zhigang and Dong, Jie and Xu, Weifeng},
title = {Comparison of AirSeal versus conventional insufflation system for retroperitoneal robot-assisted laparoscopic partial nephrectomy: a randomized controlled trial},
journal = {World Journal of Urology},
year = {2024},
volume = {42},
number = {1},
doi = {10.1007/s00345-024-04819-3}
}
EUVIMED